tradingkey.logo
tradingkey.logo
Search

Aura Biosciences Inc

AURA
Add to Watchlist
7.155USD
+0.105+1.49%
Close 07-27 16:00ETQuotes delayed by 15 min
450.66MMarket Cap
LossP/E TTM

AURA Financials

See Aura Biosciences Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Aura Biosciences Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.50/-0.40
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.76
-0.53%
Analyst Rating
BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2020Q4
Financial Indicators
EPS
8.91%-0.50
26.37%-0.38
6.47%-0.40
-13.47%-0.47
-37.59%-0.55
-4.37%-0.52
12.61%-0.42
15.09%-0.41
13.80%-0.40
4.19%-0.50
---0.48
---0.48
---0.46
---0.52
---1.44
----
----
----
----
----
----
Net Profit
-22.57%-33.69M
1.06%-25.56M
-24.18%-26.13M
-32.86%-27.02M
-39.47%-27.48M
-16.73%-25.83M
-13.67%-21.04M
-11.14%-20.34M
-12.82%-19.71M
-33.65%-22.13M
-16.42%-18.51M
-35.87%-18.30M
-36.08%-17.47M
-27.88%-16.56M
-27.15%-15.90M
---13.47M
---12.84M
-84.17%-12.95M
-124.16%-12.51M
----
---7.03M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
Operating profit
-20.08%-34.87M
2.05%-27.24M
-20.12%-27.91M
-25.71%-28.61M
-30.13%-29.04M
-12.20%-27.81M
-13.39%-23.23M
-12.26%-22.76M
-14.76%-22.31M
-40.71%-24.78M
-27.61%-20.49M
-46.76%-20.28M
-51.78%-19.44M
-51.48%-17.61M
-80.49%-16.05M
---13.82M
---12.81M
-136.85%-11.63M
-144.97%-8.89M
----
---4.91M
Net Profit
-22.57%-33.69M
1.06%-25.56M
-24.18%-26.13M
-32.86%-27.02M
-39.47%-27.48M
-16.73%-25.83M
-13.67%-21.04M
-11.14%-20.34M
-12.82%-19.71M
-33.65%-22.13M
-16.42%-18.51M
-35.87%-18.30M
-36.08%-17.47M
-27.88%-16.56M
-27.15%-15.90M
---13.47M
---12.84M
-84.17%-12.95M
-124.16%-12.51M
----
---7.03M
Current assets
-11.90%118.50M
-6.78%149.74M
-7.28%170.12M
-5.95%183.96M
-36.62%134.52M
-30.70%160.62M
19.23%183.48M
17.68%195.60M
18.49%212.25M
17.84%231.79M
32.77%153.89M
30.19%166.21M
28.33%179.12M
27.97%196.70M
38.88%115.91M
37.46%127.67M
--139.58M
--153.70M
--83.46M
--92.88M
----
Total current liabilities
37.35%16.71M
23.27%18.38M
27.93%18.82M
40.80%14.85M
25.87%12.16M
20.68%14.91M
35.07%14.71M
18.58%10.55M
19.19%9.66M
18.17%12.36M
9.33%10.89M
53.05%8.89M
62.04%8.11M
42.18%10.46M
70.88%9.96M
9.33%5.81M
--5.00M
--7.36M
--5.83M
--5.32M
----
Total assets
-11.41%137.68M
-7.16%169.43M
-7.46%190.02M
-6.36%204.40M
-33.88%155.40M
-28.45%182.50M
14.23%205.34M
13.25%218.28M
14.08%235.03M
13.91%255.07M
25.58%179.77M
42.75%192.74M
40.70%206.02M
39.93%223.94M
57.82%143.15M
36.86%135.02M
--146.42M
--160.03M
--90.70M
--98.65M
----
Total liabilities
10.92%30.43M
6.50%32.52M
8.75%33.36M
10.96%29.77M
4.55%27.43M
4.47%30.53M
9.36%30.67M
2.00%26.83M
1.87%26.24M
3.09%29.23M
-0.16%28.05M
343.54%26.30M
382.78%25.76M
267.49%28.35M
337.93%28.09M
-2.79%5.93M
--5.34M
--7.71M
--6.42M
--6.10M
----
Total equity
-16.19%107.25M
-9.91%136.91M
-10.31%156.67M
-8.79%174.63M
-38.71%127.97M
-32.71%151.97M
15.13%174.67M
15.03%191.45M
15.82%208.78M
15.47%225.85M
31.87%151.72M
28.93%166.44M
27.76%180.26M
28.41%195.58M
36.50%115.05M
39.48%129.09M
--141.09M
--152.31M
--84.29M
--92.55M
----
Net operating income
-27.99%-29.89M
14.54%-20.47M
-31.89%-20.14M
-28.81%-20.77M
4.49%-23.36M
-37.76%-23.95M
0.84%-15.27M
-10.13%-16.13M
-48.99%-24.45M
3.48%-17.39M
-43.15%-15.40M
-37.80%-14.64M
-7.97%-16.41M
-49.04%-18.01M
-23.82%-10.76M
---10.63M
---15.20M
-221.69%-12.09M
-31.43%-8.69M
----
---3.76M
Net investment
84.14%54.90M
0.43%29.82M
-545.13%-44.02M
0.69%19.98M
217.29%29.81M
132.95%29.70M
-54.28%9.89M
-7.32%19.84M
114.05%9.40M
-434.01%-90.12M
20.52%21.63M
149.28%21.41M
-162.29%-66.88M
-1960.56%-16.88M
3231.94%17.95M
---43.44M
---25.50M
-520.45%-819.00K
-467.33%-573.00K
----
---132.00K
Net financing
212.50%300.00K
409.58%2.77M
509.36%4.36M
84151.81%69.93M
-62.06%96.00K
-99.42%543.00K
-55.97%716.00K
-96.65%83.00K
25.87%253.00K
-2.33%92.98M
1463.46%1.63M
701.94%2.48M
1082.35%201.00K
18.79%95.20M
109.32%104.00K
--309.00K
--17.00K
1461.31%80.14M
-123.25%-1.12M
----
--5.13M

FAQs

What are the current assets of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its current assets were 149.74M, with a year-on-year change of -6.78.

What are the total assets of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its total assets of Aura Biosciences Inc were 169.43M, with a year-on-year change of -7.16.

What are the total liabilities of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its total liabilities of Aura Biosciences Inc were 32.52M, with a year-on-year change of 6.50.

What is the total equity of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its total equity of Aura Biosciences Inc was 136.91M, with a year-on-year change of -9.91.

What is the net operating income of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its net operating income of Aura Biosciences Inc was -112.79M, with a year-on-year change of -17.35.

What is the net investment of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its net investment of Aura Biosciences Inc was 35.59M, with a year-on-year change of -48.28.

What is the net financing of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its net financing of Aura Biosciences Inc was 77.16M, with a year-on-year change of 4737.30.

What is the Earnings Per Share (EPS) of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.76, with a year-on-year change of -0.53.

What is the net income of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its net income was -106.19M, with a year-on-year change of -22.17.

What is the Return on Equity (ROE) of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its Return on Equity (ROE) was -73.52, with a year-on-year change of -59.78.

What is the Return on Assets (ROA) of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its Return on Assets (ROA) was -60.35, with a year-on-year change of -51.90.

What is the operating profit of Aura Biosciences Inc?

According to Aura Biosciences Inc's FY2025 earnings report, its operating profit was -112.79M, with a year-on-year change of -17.35.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.